The implantable sensor points to the new Roche Diabetes Care ecosystem

Roche Diabetes Care has presented to the media and almost a hundred bloggers specialized in diabetes, their evolution of digital ecosystem in diabetes.

A digital ecosystem for the control of diabetes, to which two major novelties already known as the implantable sensor and the acquisition of the MySugg app a few months ago.Two tools that add to the Emminens E-Cononecta de Roche Diabetes Care management platform whose objective is to get people with diabetes to be as long as possible in the glycemic range.

The Swiss company has been betting on digital technology for several years as the best ally for diabetes control.A commitment to which now adds the monitoring of glucose through an implantable sensor that undoubtedly comes to revolutionize the technological industry of diabetes.A sensor that needs an incision made in a clinical environment and that is placed in the arm to measure the interstitial glucose for 90 days, that is, the one in the fat of the human body.

Those 90 days, after what is seen today in Lisbon, will rise in the next evolution of the implantable sensor to almost 150 days, which predicts a real -time diabetes control in the long term without punctures.In fact, on the occasion of the EASD Congress that is celebrated these days in Lisbon Roche Diabetes Care, it has presented a clinical study conducted during the last 6 months in which it confirms that the implantable sensor is effective in its measurement for 149 days.

The implantable sensor sends the information to a transmitter that in turn sends it to the cloud, and from there it can be managed by the MySugg app or the digital management platform.

gocarb

The GCARB app has also been presented this morning in Lisbon.It is an evolution of the app that was presented a couple of years ago in Stockholm, and its mission is to value food carbohydrates through a photo.To do this, he will use artificial intelligence and several algorithms that have been improved with respect to the first time Roche presented this project.Without a doubt, Gocarb can become a very useful educational tool for people with type 1 diabetes. For now there is a beta version not available for the public, but as we will always be attentive to continue informing.

I don't understand Fer, what is an implantable sensor?Incision?

Well then we have a lot to wait for the Gocarb application since artificial intelligence is something relatively new, which is more a concept than reality and with which they have not yet encouraged to get fully.As for the implanted sensor ... I hope it is reliability that they have appropriate is real and that their price is affordable, what I do not like is that the data to the cloud has to be transmitted and then be managed by the application,when by the NFC technology the readings could directly make the application and once in this view the graph.It is a beautiful mask to create a database of all those who use it, data on the other hand and that may be exposed to be violated by third parties.Hopefully this news of the winged sensor so that the other systems are put on the batteries and evolve their own.

The implanted sensor leaves you some small scars that no one will like to have because they do not disappear and notice leaving mark in the arms or where you put them.Luckily at least they say it lasts 150 days

Let's see this Roche sensor.There is already competition

I think that the evil will be that as always when we will have to find it, as usual, if they do not cover a sensor that usually costs € 60 less one that names how much it will cost, bone for social security, strips and puncture: ((((((((((((((((((((((((((((((((((((((((((((((((((((Thereheying ((((((((((((((((((((((same